Epic Bio to Participate in Upcoming Investor Conference

Grand News Network | November 7, 2023

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, today announced that the management will participate in an upcoming investor conference:

Stifel Healthcare Conference
Corporate presentation: Wednesday, November 15 at 10:20 a.m. ET

Institutional investors interested in meeting with ...

Full story available on Benzinga.com

Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.

Disclaimer Press Release Banner